Originally posted October 2, 2017. Updated 2026 to address a new JAMA Internal Medicine study and the current epidemiological literature.

EVIDENCE REVIEW  |  AUGUST 2026

Aircrew Radiation Risk in Perspective

Why routine lower-altitude flight is not supported by the current evidence

Originally posted October 2, 2017  |  Substantially revised in 2026 for new mortality research

Central conclusion: Routine cosmic-radiation exposure should be monitored, but current evidence does not support flying lower as a blanket cancer-prevention measure.

Concern about radiation exposure at altitude is understandable. Aircrew spend far more time at cruise altitude than passengers, cosmic ionizing radiation increases with altitude and latitude, and the exposure accumulates across a career. The Federal Aviation Administration (FAA) therefore treats it as an occupational exposure and recommends that it be managed according to the principle of keeping exposure as low as reasonably achievable.

The important words are reasonably achievable. Radiation protection is one part of an operating system that must also manage fuel, weather, turbulence, aircraft performance, air traffic constraints, range, payload, and reserve margins. A lower cruise altitude reduces cosmic-radiation dose, but it can also increase fuel consumption and may place the aircraft in a less favorable wind or weather layer. Depending on the flight, operating lower may also reduce the vertical margin available for avoiding convective weather or expose the aircraft to more turbulence or icing. Those effects are immediate and measurable. The possible cancer effect of the relatively low, chronic doses encountered in routine airline operations is estimated to be cumulative and small in absolute terms, and it is difficult to separate from other aircrew exposures.

That does not mean the radiation risk is zero. It means the evidence does not support routinely flying lower solely to reduce it. The better response is to measure and manage cumulative exposure at the operator level, preserve altitude as an operational control, and reserve altitude or route changes for circumstances in which they are actually justified — including unusual solar-radiation events.

Start by separating ultraviolet from ionizing radiation

Two different forms of radiation are often mixed together in discussions of aircrew health.

Ultraviolet radiation — primarily UV-A and UV-B — is associated with melanoma and other skin cancers. UV-B is the principal cause of sunburn, while UV-A penetrates more deeply; both contribute to skin damage and melanoma. UV-A is particularly relevant to the cockpit-exposure question because aircraft glazing generally attenuates UV-B more effectively, while some UV-A may still be transmitted. Sunscreen and physical protection can reduce ultraviolet exposure.

Ionizing radiation at altitude is different. Galactic and solar particles interact with the atmosphere and produce a mixed radiation field that includes neutrons, protons, photons, electrons, and other secondary particles. The atmosphere and Earth’s magnetic field provide shielding, so dose rates generally rise with altitude and with distance from the geomagnetic equator. Sunscreen provides no protection from this exposure.

Keeping the two exposures separate matters because an excess of melanoma in aircrew does not, by itself, identify cosmic ionizing radiation as the cause.

What the melanoma evidence actually shows

Historical studies consistently found more melanoma among pilots and cabin crew than in general-population comparisons. Miura and colleagues’ 2019 systematic review estimated melanoma incidence ratios of 2.03 for pilots and 2.12 for cabin crew. Melanoma mortality was elevated in pilots, with a pooled standardized mortality ratio of 1.99, but not significantly elevated in cabin crew.

Those findings deserve attention, but they do not resolve causation.

First, pilots and cabin crew had similar incidence estimates even though cabin crew receive little or no flight-deck ultraviolet exposure. That makes cockpit UV an unlikely explanation for the entire aircrew signal. It does not distinguish among recreational sun exposure, cosmic radiation, circadian disruption, medical surveillance, or other differences between aircrew and the comparison populations.

Second, the dose-response evidence is mixed rather than uniformly negative. Three pilot-incidence studies reviewed by Miura reported associations that tended to be linear: longer employment, greater estimated cosmic-radiation exposure, and longer flights were associated with greater melanoma risk. These studies relied on imperfect exposure surrogates, and the pattern was not reproduced as a statistically significant dose-response for pilot melanoma mortality or in cabin-crew analyses. The proper conclusion is that a cosmic-radiation contribution remains plausible but unproven — not that dose-response evidence is entirely absent. Longer flights may also correlate with longer or more frequent layovers in sunny destinations, so flight duration could partly proxy for off-duty ultraviolet exposure. The available studies cannot resolve that possibility.

Third, melanoma has relatively low sensitivity to induction by ionizing radiation compared with several other cancers. Miura noted that melanoma is generally omitted from estimates of cancers attributable to ionizing radiation, while also concluding that ionizing radiation remained a plausible explanation requiring contemporary study. Low sensitivity is a reason for caution in attribution; it is not proof of zero effect.

On the flight deck specifically, measurement results vary with aircraft type, windshield construction, direct-sun geometry, visor use, and instrumentation. Sanlorenzo and colleagues measured substantial UV-A through the acrylic windshield of a Socata TBM850 general-aviation turboprop. Cadilhac and colleagues, by contrast, detected no UV-A or UV-B in the Airbus cockpits they tested and only UV-A well below the nominal outside on-the-ground level in Boeing 777 cockpits; cockpit sun visors reduced that exposure by more than a factor of ten. In a later study covering 322 flights in Airbus A320 and A321 aircraft, Baczynska and colleagues found that average monthly UV-A exposure was low and substantially below comparable recreational exposure, although on 27 single-sector flights UV-A exposure could have exceeded ICNIRP guidance if eye protection was not used. These findings are heterogeneous rather than necessarily contradictory: they describe different aircraft, glazing, conditions, and measurement methods.

My own experience is anecdotal but still worth stating. Across a full nearly 40-year career on modern transport flight decks with thick, laminated, heated windshields, I never experienced anything resembling a sunburn despite not wearing any sun protection. That is a real observation, but it is relevant mainly to erythema-producing exposure, which is dominated by UV-B. It is consistent with strong attenuation of UV-B, but it cannot rule out lower-level or cumulative UV-A exposure and therefore cannot settle the melanoma question.

Off-duty exposure patterns may also have changed. Olsen and colleagues noted in 2019 that pilots in earlier cohorts may have had greater opportunities for sun exposure during layovers than current work practices allow. That is a plausible historical change, not proof that cockpit UV-A has become the dominant contemporary exposure. The similar pooled melanoma elevations in pilots and cabin crew make cockpit UV an incomplete explanation of the overall aircrew pattern, while leaving open the possibility that it contributes to pilot risk.

The most useful contemporary study is Olsen and colleagues’ analysis of Australian commercial pilots from 2011 through 2016. Every case was histologically confirmed. Among 91,370 person-years, the investigators found 51 invasive melanomas and 63 in-situ melanomas. The standardized incidence ratio for invasive melanoma was 1.20, with a 95% confidence interval of 0.89 to 1.55. That was not statistically significant, but the interval still permits anything from a modest reduction to a clinically meaningful increase.

In-situ melanoma was elevated in the primary analysis. The estimate was attenuated and no longer statistically significant when the investigators modeled increasing background detection rates. The body-site distribution also did not show an excess on the head, neck, or upper limbs that would be expected if occupational cockpit sunlight were the primary cause.

This modern study is reassuring, but it does not erase the historical evidence. It covered six years, included only 51 invasive cases, and examined a heterogeneous group of male Australian commercial-license holders, only about half of whom held airline transport pilot licenses. Its appropriate implication is that the historical twofold estimate may not describe contemporary pilots in every operating environment.

The widely repeated claim that New Zealand pilots had 50 times the melanoma rate of the general population should not be used as a risk estimate. In that study, pilots reported lifetime melanoma histories on medical questionnaires, while the comparison figure came from registry-confirmed diagnoses. The ascertainment methods and time bases were not comparable. Later systematic reviews appropriately excluded it.

The practical conclusion is straightforward: aircrew should take melanoma prevention and surveillance seriously, but the existing melanoma literature cannot be treated as a direct measurement of cancer caused by cosmic radiation.

Kidney stones: a more immediate but less exotic concern

The New Zealand morbidity study also found more reported kidney or bladder disease among pilots than in an age-matched male comparison group: 3.3% versus 0.6%. The pilot diagnoses were reportedly almost all renal calculi. The authors proposed in-flight dehydration, voluntary fluid restriction, limited opportunities to leave the flight deck, and short turnarounds as possible explanations.

This evidence is suggestive, not conclusive. The study included 595 pilots from one airline, used self-reported medical histories, and compared a broad kidney-or-bladder category across datasets. A separate analysis of the FAA medical-certification database found renal-calculi prevalence slightly below the general-population estimate and declining over time.

Still, the proposed mechanism is credible and the preventive measure is comparatively simple: operators should make hydration and reasonable lavatory access operationally feasible, and pilots should avoid using chronic fluid restriction as a workload-management strategy. This is a better example of risk management than searching for a single exotic explanation for every aircrew health difference.

What we know about routine cosmic-radiation exposure

Aircrew exposure is real. Depending on routes, altitude, latitude, solar conditions, and time aloft, annual effective doses are commonly estimated in the range of approximately 3 to 6 millisieverts for highly exposed crew members. The FAA cites an average occupational aircrew dose of about 3 mSv per year and recognizes galactic cosmic radiation at cruise altitude as an occupational exposure.

For context, FAA Advisory Circular 120-61B accepts a recommended occupational limit averaging 20 mSv per year over five years, with no more than 50 mSv in a single year. Those are upper limits, not boundaries between safe and dangerous exposure. The FAA also recommends that a pregnant crewmember limit exposure of the conceptus to no more than 0.5 mSv per month.

At these low doses, risk is estimated rather than directly observable in an individual. The FAA states that any ionizing-radiation exposure may increase cancer risk, but that the estimated increase at the doses normally encountered in flight is very small and cannot be identified as the cause of disease in a particular person. That is a precautionary position: the risk is treated as nonzero, but small enough that it must be managed in proportion to the activity and to other public-health and safety considerations.

The largest pooled mortality study remains informative. Hammer and colleagues followed 93,771 commercial airline crew members from ten countries for approximately two million person-years. Overall mortality was substantially lower than expected in male cockpit crew and female cabin crew. Mortality from the study’s group of radiation-related cancers was lower in male cockpit crew and approximately equal to the general population in male and female cabin crew. Breast-cancer, leukemia, and brain-cancer mortality were not elevated overall. Melanoma mortality was the notable exception and was significantly elevated in male cockpit crew.

These findings are consistent with a strong healthy-worker effect and do not demonstrate a substantial increase in overall cancer mortality from routine cosmic exposure. They also do not prove that the exposure contributes nothing. Historical exposure reconstruction was imperfect, individual doses varied, and several occupational exposures travel together.

A 2026 National Academies consensus report — directed by Congress under the 2024 FAA Reauthorization Act, sponsored by the Department of Transportation, and chaired by epidemiologist Jonathan Samet — reached compatible conclusions. The occupational context is important. In the U.S. comparison in NCRP Report 160, summarized by Patel and colleagues, aircrew had the largest mean annual effective dose of ionizing radiation among the occupational groups evaluated. The National Academies report also found that flight crewmembers lack protections comparable to those provided to many other radiation-exposed workers. At the same time, existing studies do not establish that cosmic radiation causes the specific cancers observed in aircrew. The committee concluded that the well-documented melanoma excess in cockpit crew is attributed in the literature to ultraviolet rather than cosmic radiation, that the causes of the breast-cancer excess in flight attendants remain uncertain, and that evidence concerning several other cancers is mixed or inconclusive. It recommended FAA-led radiation-safety programs, cumulative dose tracking, improved models, coordinated long-term research, and scheduling options for crewmembers seeking lower-dose routes, including pregnant crewmembers. It did not recommend routine altitude reduction as a blanket control.

What the 2026 JAMA study adds — and what it cannot establish

In August 2026, Patel, Liu, and Jena reported that flight attendants and pilots ranked first and second among 503 occupations for the risk-adjusted proportion of deaths assigned to a selected group of “radiation-related” cancers. Among 12.7 million death records from 2020 through 2024, 6.9% of flight-attendant deaths and 6.7% of pilot deaths fell within that group. Site-specific odds were significantly elevated for breast, central-nervous-system, and prostate cancers and melanoma in both groups, and for leukemia in pilots.

This is a legitimate signal, but it is not a mortality-rate study.

The analysis began with people who had died and asked which cause accounted for each death. It had no living aircrew population, person-time denominator, cancer incidence data, individual flight history, cumulative dose, route, altitude, or duration of employment. It therefore cannot tell us how many cancer deaths occurred per 100,000 pilots or per 100,000 person-years, and it cannot estimate the additional absolute risk produced by flying.

Proportional mortality is also sensitive to competing causes of death. If pilots die less often from cardiovascular disease, chronic pulmonary disease, diabetes, or other common causes, cancer can occupy a larger share of pilot deaths even when the cancer mortality rate is not elevated. Historical cohort studies demonstrate that aircrew have had markedly lower overall and cardiovascular mortality, so this denominator mechanism is plausible. The JAMA data cannot determine how much of the new finding it explains.

The healthy-worker effect cuts in both directions depending on the measure. In a rate-based cohort comparison, selecting and medically screening a healthy workforce can suppress apparent mortality and make a true occupational effect harder to detect. In a decedent-only proportional analysis, the same reduction in competing causes can inflate cancer’s share of deaths. The JAMA analysis is of the second kind, so this denominator effect is live and unquantified in its result.

Several other limitations matter:

1. “Usual occupation” was taken from death certificates and was generally supplied by an informant through a funeral director. It does not establish airline employment, active medical certification, exposure duration, or latency.
2. The radiation-related composite was selected partly from cancers previously reported as elevated in aircrew. The selection also used radiobiological models and evidence from other radiation-exposed populations, so it was not wholly circular, but ranking aircrew on an outcome partly informed by earlier aircrew findings reduces the independence of the result.
3. Lung cancer was excluded because smoking could not be controlled, while melanoma, breast cancer, and prostate cancer — each with important non-radiation determinants — remained in the composite.
4. Ground-based mechanics and assemblers were not matched controls. The supplement explicitly states that they were included only to test whether exposure to aircraft and the aviation environment could explain the result.
5. The analysis covered the pandemic-era years 2020 through 2024. Occupational differences in COVID-19 and other competing mortality could affect cause-of-death proportions.
6. The study could not control for circadian disruption, reproductive history, detailed health behavior, screening, or individual socioeconomic differences.

In their accompanying commentary, Olsen and Karipidis argue that the concentration of the excess in the selected radiation-related cancers — without a comparable pattern in non-radiation cancers or ground-based aviation workers — “supports the hypothesis that occupational radiation exposure, rather than lifestyle or socioeconomic factors, underlies the observed excess.” That hypothesis deserves investigation, but this decedent-only analysis contains no individual exposure data capable of assigning the observed pattern to cosmic radiation rather than to other features of aircrew work. For a traveling workforce, occupational and lifestyle exposures are not mutually exclusive. Employment can determine where crewmembers spend their off-duty time and can thereby create opportunities for intermittent solar exposure that would not exist in the same form for the home-country comparison population. Ultraviolet exposure during a layover may therefore be occupation-enabled, but it is not the altitude-dependent cosmic ionizing radiation that flying lower would reduce.

My experience as a manager at a major airline illustrates this classification problem. Injuries sustained during reasonable layover activities could be treated as occupational workers’ compensation claims because the employment placed the crewmember at that destination. Coverage is fact- and jurisdiction-dependent, and the legal treatment does not establish medical causation. It does demonstrate why an activity occurring off duty cannot automatically be treated as independent of the occupation. Consistent with that point, an Icelandic study found that pilots and cabin crew reported more sunny vacations than the comparison population, although the investigators concluded that the measured differences were not large enough to explain the entire melanoma excess (although that would, again, ignore the occupational-related requisite layovers with an associated large opportunity to be outside in the sun). No available study directly measured cumulative ultraviolet dose during layovers, so occupation-enabled UV remains a plausible but unquantified pathway rather than an established explanation.

The published evidence also does not establish that northern-based cohorts have a higher melanoma rate than a separately defined long-haul population. The principal meta-analysis found no statistical evidence of heterogeneity among the pilot-incidence studies and did not conduct a latitude-based comparison. Internal analyses used correlated surrogates such as employment duration, total flight hours, estimated radiation dose, aircraft category, and world or long-distance flying. These measures do not isolate a mechanism. Short-haul flying introduces another confound: shorter sectors commonly spend less time at the highest or most efficient cruise levels and may be operated at lower cruise altitudes, while exposing crews to more climb-and-descent cycles, sectors, daylight operations, ramp activity, and potentially different layover patterns. Long-haul flying adds duration and time-zone displacement, but duration does not necessarily imply a high-latitude route. Because altitude, geomagnetic latitude, flight duration, route structure, era, and off-duty exposure patterns vary together, neither a short-haul nor a long-haul association can be translated directly into a cosmic-radiation effect.

The broader specificity argument therefore does not resolve the mechanism. Aircrew employment bundles cosmic ionizing radiation with possible cockpit and off-duty ultraviolet exposure, circadian disruption, reproductive differences, and other health or diagnostic patterns. Ground-based aviation workers do not share that entire exposure structure. The composite itself compounds the problem. It includes a cancer strongly associated with ultraviolet radiation (melanoma) and several cancers whose observed patterns may reflect non-radiation influences, including reproductive, hormonal, circadian, screening, and diagnostic factors. IARC classifies night-shift work as probably carcinogenic overall, but describes the human evidence for breast and prostate cancer as limited rather than definitive. Finding specificity to the selected cancer composite distinguishes aircrew from other occupations, but it does not distinguish cosmic ionizing radiation from the other exposures bundled with airborne work. Olsen and Karipidis are right about the needed next step: prospective cohort studies with validated individual-level estimates of cosmic dose, ultraviolet exposure, and circadian disruption. That recommendation is itself an acknowledgment that the present data cannot apportion cause or quantify the effect of any single exposure.

The study should therefore neither be dismissed nor translated into “flying causes cancer.” It identifies a contemporary pattern that warrants dose-linked cohort research. It does not overturn the rate-based literature or quantify the cancer risk from cosmic radiation.

Circadian disruption belongs in the analysis

Aircrew do not experience radiation in isolation. Night work, repeated time-zone crossings, irregular sleep opportunity, and fatigue occur in the same occupational setting.

In 2020, the International Agency for Research on Cancer classified night-shift work as probably carcinogenic to humans, Group 2A. Its definition includes transmeridian air travel. The classification was based on limited evidence in humans for breast, prostate, colon, and rectal cancers, together with stronger animal and mechanistic evidence.

This overlap is important because breast and prostate cancer were among the significant JAMA findings. Circadian disruption is therefore a credible competing or contributing pathway. It is not a proven explanation of the JAMA pattern, and it does not exclude a radiation contribution. It demonstrates why an occupation label without individual exposure histories cannot separate the relevant mechanisms.

Put the altitude question in proportion to established cancer risks

An evidence-based comparison must distinguish between a population-attributable burden and an individual’s change in risk. Those are different measures and cannot be converted directly into one another. Even with that limitation, the established prevention literature shows where the larger and more certain opportunities lie.

Using 2019 United States data, Islami and colleagues estimated that 40.0% of incident cancers and 44.0% of cancer deaths in adults aged 30 years or older were attributable to the modifiable factors they evaluated. Cigarette smoking alone accounted for an estimated 19.3% of cancer cases and 28.5% of cancer deaths. Excess body weight accounted for 7.6% of cases and 7.3% of deaths, and alcohol consumption for 5.4% of cases and 4.1% of deaths. The study also attributed additional cancer burden to dietary factors, physical inactivity, ultraviolet exposure, and infections.

The individual effect of smoking is not subtle. Current smokers are approximately 15 to 30 times more likely to develop or die from lung cancer than people who do not smoke, and smoking causes about one-third of cancer deaths in the United States. Alcohol is also an established human carcinogen. It causes cancers of the oral cavity, pharynx, larynx, esophagus, colorectum, liver, and female breast, with risk increasing as consumption rises. A global IARC-led analysis attributed approximately 741,000 new cancer cases in 2020 — 4.1% of all new cases — to alcohol; light and moderate drinking contributed about 14% of that alcohol-attributable burden.

Diet requires more precise language than simply warning about “fatty foods.” Dietary fat by itself is not a single, consistently demonstrated cause of cancer. The stronger evidence concerns excess body weight, processed meat, red meat, low dietary fiber, and overall dietary pattern. IARC classifies processed meat as carcinogenic to humans on the basis of sufficient evidence for colorectal cancer; consuming about 50 grams per day has been associated with an approximately 18% relative increase in colorectal-cancer risk. Red meat is classified as probably carcinogenic, with the clearest evidence again involving colorectal cancer. High-calorie diets rich in fatty or sugary foods matter chiefly because they can promote excess body weight, which is associated with several cancers.

Night work belongs in the same priority discussion, but it should not be presented as a simple lifestyle choice for aircrew. IARC classifies night-shift work, including transmeridian air travel, as probably carcinogenic. The magnitude of the individual cancer effect remains less certain than for smoking, and the appropriate controls include scheduling, fatigue management, and protection of sleep opportunity at the organizational level.

None of these comparisons proves that cosmic radiation is harmless, and the available evidence does not support a precise claim that one exposure is a fixed number of times worse than another. A descent of one or several flight levels produces a real, modelable reduction in radiation dose. What has not been demonstrated is a corresponding reduction in cancer outcomes from routinely planning airline flights a few thousand feet lower. For someone seeking to reduce overall cancer risk, avoiding tobacco, reducing alcohol, maintaining a healthy body weight, following a healthy dietary pattern, remaining physically active, and limiting ultraviolet exposure provide larger or better-established opportunities for prevention. Appropriate screening can improve early detection and outcomes and, for some cancers, identify precancerous lesions. For operators, circadian health and fatigue are additional occupational targets that a lower cruise altitude would not address.

Why routine lower-altitude flight is the wrong response

The physical premise is correct: at a given location, cosmic-radiation dose rate generally increases with altitude. Flying lower reduces dose. The operational conclusion does not automatically follow.

Cruise altitude is selected for the aircraft and the flight actually being conducted. Weight, temperature, winds, turbulence, convective weather, icing, airspace, traffic, range, fuel, engine-out considerations, and destination conditions all matter. A lower altitude can be the safest or most efficient choice on a particular flight. On another flight it can increase fuel burn, trip cost, or time, reduce range or payload efficiency, or place the aircraft in a less favorable weather layer that exposes the flight to more turbulence, icing, or convective-weather constraints. ICAO performance material expressly recognizes that fuel consumption is generally lower at higher cruise altitudes and treats unnecessary altitude constraints as a source of avoidable fuel burn.

Although it would be inaccurate to claim that lower flight is always more dangerous, it is equally inaccurate to treat routine altitude reduction as a cost-free health intervention. The comparison must be made for a specific flight, not as a slogan.

FAA Advisory Circular 120-61B provides the right framework. Its definition of keeping exposure as low as reasonably achievable requires consideration of technology, economics, public health, safety, and the activity being performed. For routine galactic-cosmic exposure, the estimated health increment is small and cumulative, while the fuel and operational effects of a deliberately suboptimal altitude are immediate and measurable. On the present evidence, routinely biasing airline operations toward lower altitudes solely to reduce long-term cancer risk would be a disproportionate control.

There is an important exception. During a significant solar-particle event, dose rates can rise rapidly, particularly on high-latitude routes. The FAA states that responding to a solar-radiation alert by descending can significantly reduce exposure in high-latitude areas of concern. NOAA likewise notes that severe events may require rerouting for both radiation and communications reasons. In that situation, lower altitude or a different route is a response to a defined hazard, supported by current information and weighed against the operational consequences.

The distinction is the heart of sound risk management:

1. Routine operations: use dose modeling, cumulative monitoring, scheduling, education, and occupational-health controls; do not prescribe lower altitude as a blanket mitigation.
2. Higher individual susceptibility or exposure: manage pregnancy, unusually radiation-intensive schedules, and other individual circumstances through informed occupational-health and scheduling decisions.
3. Major solar event: use current alerts and consider route or altitude changes through the operator’s dispatch and operational-control system.

A proportionate approach for aircrew and operators

The United States should treat aircrew more consistently with other occupationally exposed workers. A credible program would:

1. estimate cumulative dose using route-, date-, latitude-, and altitude-sensitive tools such as the FAA’s CARI models;
2. give crewmembers access to their estimated exposure histories;
3. establish clear pregnancy and high-exposure scheduling procedures;
4. integrate NOAA and FAA solar-radiation alerts into dispatch and operational control;
5. support contemporary longitudinal research linking individual dose and circadian metrics to cancer incidence and mortality; and
6. address the more immediate occupational controls that are already actionable, including sleep opportunity, fatigue, hydration, and UV protection.

For individual aircrew members, ordinary cancer prevention remains important: avoid tobacco, follow evidence-based screening advice, protect skin from UV exposure, and seek evaluation of changing skin lesions. Sleep and circadian health should be treated as organizational as well as individual concerns; a pilot cannot personally “discipline” away a schedule that repeatedly conflicts with biological night.

The bottom line

Aircrew cosmic-radiation exposure is real, occupational, and worth monitoring. The current evidence does not establish that it produces a substantial increase in overall cancer mortality, nor does it justify calling the risk zero. Historical cohorts are broadly reassuring, melanoma remains unresolved, and the 2026 JAMA study adds a cause-of-death signal that cannot be converted into an absolute or causal risk estimate.

For routine airline operations, the evidence supports the hypothesis that the uncertain incremental cancer risk from ordinary cosmic exposure is smaller than — and should not displace — the immediate, measurable operational considerations used to select a safe and efficient altitude. That is not an argument for always flying higher. It is an argument for preserving altitude as an operational control and managing chronic radiation by the methods best suited to a chronic occupational exposure: estimation, monitoring, scheduling, research, and targeted action when conditions materially change.

During a serious solar-radiation event, the balance can change, and lower altitude or rerouting may be warranted. That exception strengthens the general rule because it ties the intervention to a defined hazard rather than to fear alone.

Good risk management does not require us to deny uncertain risks. It requires us to measure them as well as we can, compare them with the consequences of the proposed control, and act where the evidence says the intervention will do more good than harm.

References

1. Patel VR, Liu M, Jena AB. Cancer-related mortality among US pilots and flight attendants. JAMA Internal Medicine. Published online August 17, 2026. doi:10.1001/jamainternmed.2026.3635.
2. Olsen CM, Karipidis K. Cancer mortality in aircrew — high altitude, hard questions. JAMA Internal Medicine. Published online August 17, 2026. doi:10.1001/jamainternmed.2026.3632.
3. National Academies of Sciences, Engineering, and Medicine. Assessing Radiation Exposure, Health Outcomes, and Mitigation Strategies for Flight Crewmembers. Washington, DC: The National Academies Press; 2026. doi:10.17226/29261.
4. Hammer GP, Auvinen A, De Stavola BL, et al. Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries. Occupational and Environmental Medicine. 2014;71(5):313-322. doi:10.1136/oemed-2013-101395.
5. Miura K, Olsen CM, Rea S, Marsden J, Green AC. Do airline pilots and cabin crew have raised risks of melanoma and other skin cancers? Systematic review and meta-analysis. British Journal of Dermatology. 2019;181(1):55-64. doi:10.1111/bjd.17586.
6. Olsen CM, Miura K, Dusingize JC, et al. Melanoma incidence in Australian commercial pilots, 2011-2016. Occupational and Environmental Medicine. 2019;76(7):462-466. doi:10.1136/oemed-2018-105676.
7. Sanlorenzo M, Wehner MR, Linos E, et al. The risk of melanoma in airline pilots and cabin crew: a meta-analysis. JAMA Dermatology. 2015;151(1):51-58. doi:10.1001/jamadermatol.2014.1077.
8. Scheibler C, Toprani SM, Mordukhovich I, et al. Cancer risks from cosmic radiation exposure in flight: a review. Frontiers in Public Health. 2022;10:947068. doi:10.3389/fpubh.2022.947068.
9. Sykes AJ, Larsen PD, Griffiths RF, Aldington S. A study of airline pilot morbidity. Aviation, Space, and Environmental Medicine. 2012;83(10):1001-1005. doi:10.3357/ASEM.3380.2012.
10. Cadilhac P, Bouton MC, Cantegril M, et al. In-flight ultraviolet radiation on commercial airplanes. Aerospace Medicine and Human Performance. 2017;88(10):947-951. doi:10.3357/AMHP.4852.2017.
11. Sanlorenzo M, Vujic I, Posch C, Cleaver JE, Quaglino P, Ortiz-Urda S. The risk of melanoma in pilots and cabin crew: UV measurements in flying airplanes. JAMA Dermatology. 2015;151(4):450-452. doi:10.1001/jamadermatol.2014.4643.
12. Baczynska KA, Brown S, Chorley AC, et al. In-flight UV-A exposure of commercial airline pilots. Aerospace Medicine and Human Performance. 2020;91(6):501-510. doi:10.3357/AMHP.5507.2020.
13. Rafnsson V, Hrafnkelsson J, Tulinius H, Sigurgeirsson B, Olafsson JH. Risk factors for cutaneous malignant melanoma among aircrews and a random sample of the population. Occupational and Environmental Medicine. 2003;60(11):815-820. doi:10.1136/oem.60.11.815.
14. IARC Working Group on the Identification of Carcinogenic Hazards to Humans. Night Shift Work. IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 124. International Agency for Research on Cancer; 2020.
15. Federal Aviation Administration. Advisory Circular 120-61B: In-Flight Radiation Exposure. November 21, 2014. https://www.faa.gov/documentLibrary/media/Advisory_Circular/AC_120-61B.pdf.
16. Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. Cancer in aircrew. Updated 2024. https://www.cdc.gov/niosh/aviation/prevention/aircrew-cancer.html.
17. Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. Aircrew and cosmic ionizing radiation. https://www.cdc.gov/niosh/aviation/prevention/aircrew-radiation.html.
18. International Civil Aviation Organization. Global Air Navigation Plan performance-management data: fuel efficiency and cruise altitude. https://ganpportal.icao.int/PerformanceManagement/DataAnalytics.
19. National Oceanic and Atmospheric Administration. The effects of space weather on Earth: aviation. https://www.nesdis.noaa.gov/our-environment/space-weather/the-effects-of-space-weather-earth.
20. National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. National Academies Press; 2006.
21. Islami F, Marlow EC, Thomson B, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA: A Cancer Journal for Clinicians. 2024;74(5):405-432. doi:10.3322/caac.21858.
22. Centers for Disease Control and Prevention. Health effects of cigarettes: cancer. Updated September 17, 2024. https://www.cdc.gov/tobacco/about/cigarettes-and-cancer.html.
23. Rumgay H, Shield K, Charvat H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. The Lancet Oncology. 2021;22(8):1071-1080. doi:10.1016/S1470-2045(21)00279-5.
24. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Red Meat and Processed Meat. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 114. International Agency for Research on Cancer; 2018.
25. National Cancer Institute. Alcohol and cancer risk fact sheet. Updated 2025. https://www.cancer.gov/about-cancer/causes-prevention/risk/alcohol/alcohol-fact-sheet.
26. National Council on Radiation Protection and Measurements. Ionizing Radiation Exposure of the Population of the United States. NCRP Report No. 160. Bethesda, MD: NCRP; 2009.